E-cigarette, or vaping, product use-associated lung injury (EVALI) emerged as a significant health concern in 2019, with many patients requiring intensive care. Understanding its pulmonary implications is crucial for effective management and prevention.
This explainer provides insights into the health impacts of EVALI, emphasizing the importance of awareness among healthcare providers, policymakers, and the public to mitigate risks associated with vaping products.